Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Acasti Pharma Inc. | Director, 10%+ Owner | Common Shares | 1.19M | $2.2M | $1.85 | Sep 25, 2023 | Indirect |
Acasti Pharma Inc. | Director, 10%+ Owner | Common Warrants (right to buy) | 423K | Sep 25, 2023 | Indirect | ||
Acasti Pharma Inc. | Director, 10%+ Owner | Stock Options (Right to Buy) | 10K | Dec 19, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ACST | Acasti Pharma Inc. | Dec 19, 2023 | 1 | $0 | 4 | Dec 20, 2023 | Director, 10%+ Owner |
ACST | Acasti Pharma Inc. | Sep 25, 2023 | 2 | $1.3M | 4 | Sep 27, 2023 | Director, 10%+ Owner |
ACST | Acasti Pharma Inc. | Jul 14, 2023 | 1 | $0 | 4 | Jul 18, 2023 | Director |
ACST | Acasti Pharma Inc. | Sep 28, 2022 | 1 | $0 | 4 | Sep 30, 2022 | Director |
ACST | Acasti Pharma Inc. | Nov 12, 2021 | 1 | $0 | 4 | Nov 16, 2021 | Director |
ACST | Acasti Pharma Inc. | Aug 27, 2021 | 0 | $0 | 3 | Sep 28, 2021 | Director |